Recap: NeuroOne Medical Tech Q1 Earnings
Portfolio Pulse from Benzinga Insights
NeuroOne Medical Tech (NASDAQ:NMTC) reported its Q1 earnings on February 13, 2024, with an EPS of $-0.14, matching estimates. Revenue increased by $863K from the previous year. Despite matching EPS estimates this quarter, past performance shows a significant share price drop following earnings that beat estimates.
February 13, 2024 | 9:05 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
NeuroOne Medical Tech reported Q1 earnings with an EPS of $-0.14, in line with estimates, and a significant year-over-year revenue increase.
While NMTC's earnings matched expectations, its history of share price volatility post-earnings, especially after beating estimates, suggests a cautious outlook. The significant revenue increase YOY is positive, but the market's focus may remain on EPS performance and historical price reactions.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100